Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Goodkin

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2000
1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MSJ Suhy, W D Rooney, D E Goodkin, et al.
Neurology|December 17, 1998
A serial study of new MS lesions and the white matter from which they ariseD E Goodkin, W D Rooney, R Sloan, et al.
Neurology|April 6, 2000
A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosisD E Goodkin, M Shulman, J Winkelhake, et al.
Neurogenetics|November 21, 2001
Linkage and association analysis of chromosome 19q13 in multiple sclerosisM A Pericak-Vance, J B Rimmler, E R Martin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 1995
A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG)L D Jacobs, D L Cookfair, R A Rudick, et al.
Immunogenetics|May 10, 2000
CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics GroupL F Barcellos, A M Schito, J B Rimmler, et al.
Human Molecular Genetics|July 21, 1998
Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics GroupJ L Haines, H A Terwedow, K Burgess, et al.
Neurology|May 22, 1998
Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG)R A Rudick, N A Simonian, J A Alam, et al.
Neurology|July 17, 1999
A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)J H Simon, L D Jacobs, M K Campion, et al.
Neurology|July 26, 2000
A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Multiple Sclerosis Collaborative Research GroupJ H Simon, J Lull, L D Jacobs, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2000
1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MSJ Suhy, W D Rooney, D E Goodkin, et al.
Neurology|December 17, 1998
A serial study of new MS lesions and the white matter from which they ariseD E Goodkin, W D Rooney, R Sloan, et al.
Neurology|April 6, 2000
A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosisD E Goodkin, M Shulman, J Winkelhake, et al.
Neurogenetics|November 21, 2001
Linkage and association analysis of chromosome 19q13 in multiple sclerosisM A Pericak-Vance, J B Rimmler, E R Martin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 1995
A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG)L D Jacobs, D L Cookfair, R A Rudick, et al.
Immunogenetics|May 10, 2000
CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics GroupL F Barcellos, A M Schito, J B Rimmler, et al.
Human Molecular Genetics|July 21, 1998
Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics GroupJ L Haines, H A Terwedow, K Burgess, et al.
Neurology|May 22, 1998
Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG)R A Rudick, N A Simonian, J A Alam, et al.
Neurology|July 17, 1999
A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)J H Simon, L D Jacobs, M K Campion, et al.
Neurology|July 26, 2000
A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Multiple Sclerosis Collaborative Research GroupJ H Simon, J Lull, L D Jacobs, et al.
Pageof 9